UW
Uri Weinberg
Chf Medical and Innovation Ofr

Uri Weinberg insider trades: NovoCure (NVCR) stock sales

Chf Medical and Innovation Ofr, NovoCure Last trade Mar 4, 2026 22 Form 4 filings
$232K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2020
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Uri reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 4, 2026NVCR↓ Sell$85K
Mar 2, 2026NVCR↓ Sell$147K
Mar 3, 2025NVCR↓ Sell$5K
Feb 28, 2025NVCR↓ Sell$87K
Jan 5, 2023NVCR↓ Sell$946K
May 10, 2021NVCR↓ Sell$1.1M
Mar 23, 2021NVCR↓ Sell$545K
Feb 22, 2021NVCR↓ Sell$1.1M
Sep 25, 2020NVCR↓ Sell$1.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NVCR insiders

Open-market trades in the last 12 months

About Uri Weinberg's insider trades

Uri Weinberg is Chf Medical and Innovation Ofr at NovoCure (NVCR). Since Sep 25, 2020, Uri has reported no open-market purchases and 9 sales worth $5.6M on SEC Form 4. In the last 12 months: 2 sales ($232K).

Their filings also include grants and awards (14 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.